By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

SYGNIS Pharma AG 

Im Neuenheimer Feld 515

Heidelberg    69120  Germany
Phone: 49 6221 454 6 Fax: 49 6221 454 700


SEARCH JOBS


Industry
Pharmaceutical






Company News
SYGNIS Signs Non-Exclusive Distribution Agreement With Scandinavian Biotop Oy For Finland 6/17/2015 9:14:15 AM
SYGNIS Signs Second Non-Exclusive Distribution Agreement For Asia With Welgene Biotech Co., Ltd. In Taiwan 6/11/2015 9:15:20 AM
SYGNIS Announces Global Launch Of Trueprime RCA Kit For The Direct Amplification Of Circular DNA Targets 6/8/2015 9:12:22 AM
SYGNIS Announces Genetrix S.L. Has Taken Over All Shares From Genetrix Life Sciences AB To Become New Majority Shareholder 6/3/2015 8:31:11 AM
SYGNIS Reports Results For The First Quarter 2015 5/13/2015 11:58:01 AM
SYGNIS Signs Non-Exclusive Distribution Agreement With Cambridge Bioscience Ltd For UK And Ireland 5/4/2015 7:13:38 AM
SYGNIS Reports Financial Results For Fiscal Year 2014 4/29/2015 8:39:11 AM
SYGNIS To Host Live Webinar On Its Revolutionary TrueprimeTechnology For Primer-Free Whole Genome Amplification (WGA) 3/11/2015 8:55:55 AM
SYGNIS Pharma AG Presents Its First Own Product Line Based On PrimPol Technology: TruePrime 11/20/2014 11:15:32 AM
SYGNIS Pharma AG Release: GBC Research Reiterates “BUY” Recommendation For SYGNIS Shares With Price Target Of €4.05 11/19/2014 1:33:08 PM
1234567
//-->